MX2009006881A - Procesos para la preparacion de antagonistas del receptor ccr-5 utilizando compuestos de 1-ciclopropan-sulfonil-piperidinilo 4-sustituido. - Google Patents
Procesos para la preparacion de antagonistas del receptor ccr-5 utilizando compuestos de 1-ciclopropan-sulfonil-piperidinilo 4-sustituido.Info
- Publication number
- MX2009006881A MX2009006881A MX2009006881A MX2009006881A MX2009006881A MX 2009006881 A MX2009006881 A MX 2009006881A MX 2009006881 A MX2009006881 A MX 2009006881A MX 2009006881 A MX2009006881 A MX 2009006881A MX 2009006881 A MX2009006881 A MX 2009006881A
- Authority
- MX
- Mexico
- Prior art keywords
- cyclopropane
- sulfonyl
- substituted
- ccr
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
La presente invención revela un proceso nuevo para preparar compuestos de 1-ciclopropan-sulfonil-piperidinilo 4-sustituido, que son intermediarios útiles para la preparación de antagonistas del receptor CCR5 y por lo tanto útiles para el tratamiento de mamíferos infectados por el virus VIH. Específicamente revela un proceso nuevo para sintetizar compuestos de 4-[4-[(R)-[1-[ciclopro pilsulfonil)-4-piperidinil](3-fluorofenil)metil]-3(S)-metil-1-pip erazinil]-1-[(4,6-dimetil-5-pirimidinil)carbonil]-4-metilpiperidi na].
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87688806P | 2006-12-22 | 2006-12-22 | |
PCT/US2007/026049 WO2008079284A1 (en) | 2006-12-22 | 2007-12-20 | Process for preparing ccr-5 receptor antagonists utilizing 4-substituted 1-cyclopropane-sulfonyl-piperidinyl compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009006881A true MX2009006881A (es) | 2009-07-03 |
Family
ID=39367127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009006881A MX2009006881A (es) | 2006-12-22 | 2007-12-20 | Procesos para la preparacion de antagonistas del receptor ccr-5 utilizando compuestos de 1-ciclopropan-sulfonil-piperidinilo 4-sustituido. |
Country Status (7)
Country | Link |
---|---|
US (1) | US20100063280A1 (es) |
EP (1) | EP2125733A1 (es) |
JP (1) | JP2010513521A (es) |
AR (1) | AR064502A1 (es) |
CA (1) | CA2673233A1 (es) |
MX (1) | MX2009006881A (es) |
WO (1) | WO2008079284A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7697827B2 (en) | 2005-10-17 | 2010-04-13 | Konicek Jeffrey C | User-friendlier interfaces for a camera |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60236218D1 (de) * | 2001-03-29 | 2010-06-10 | Schering Corp | CCR5 Antagonisten verwendbar für die Behandlung von Aids |
PE20040769A1 (es) * | 2002-12-18 | 2004-11-06 | Schering Corp | Derivados de piperidina utiles como antagonisas ccr5 |
CA2594114A1 (en) * | 2005-01-06 | 2006-07-13 | Schering Corporation | Synthesis of ccr5 receptor antagonists |
-
2007
- 2007-12-20 CA CA002673233A patent/CA2673233A1/en not_active Abandoned
- 2007-12-20 MX MX2009006881A patent/MX2009006881A/es unknown
- 2007-12-20 EP EP07863166A patent/EP2125733A1/en not_active Withdrawn
- 2007-12-20 JP JP2009542920A patent/JP2010513521A/ja not_active Withdrawn
- 2007-12-20 WO PCT/US2007/026049 patent/WO2008079284A1/en active Application Filing
- 2007-12-20 US US12/519,729 patent/US20100063280A1/en not_active Abandoned
- 2007-12-21 AR ARP070105867A patent/AR064502A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR064502A1 (es) | 2009-04-08 |
US20100063280A1 (en) | 2010-03-11 |
CA2673233A1 (en) | 2008-07-03 |
EP2125733A1 (en) | 2009-12-02 |
WO2008079284A1 (en) | 2008-07-03 |
JP2010513521A (ja) | 2010-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY153719A (en) | Prokineticin 1 receptor antagonists | |
WO2007119106A3 (en) | Processes for preparing intermediate compounds useful for the preparation of ezetimibe | |
NO20092762L (no) | 2-aza-bicyklo[3.1.0]heksanderivater | |
TW200716566A (en) | Prokineticin 2 receptor antagonists | |
WO2007127297A3 (en) | Crystalline forms of a dimethylphenyl compound | |
WO2007079163A3 (en) | Prokineticin 1 receptor antagonists | |
EE200100248A (et) | Omeprasooli uus kristalne vorm | |
DE60224404D1 (de) | Substiuierte piperidine als melanocortinrezeptor-modulatoren | |
TW200613296A (en) | Crystalline form of a biphenyl compound | |
NO20050429L (no) | Substituert kinolin-CCR5-reseptorantagonister | |
MX2010003001A (es) | Derivados de quinolina como antagonistas del receptor de la 5-hidroxitriptamina 5a. | |
TW200621245A (en) | Thienopyridinone compounds and methods of treatment | |
NO20060417L (no) | Fremgangsmate til fremstilling av 1-okten fra krakk-C4 | |
MXPA05004507A (es) | 4-amino-1-(piridilmetil)piperidina sustituida como antagonista del receptor muscarinico. | |
ATE334965T1 (de) | Piperidinverbindungen als muscarinantagonisten | |
MX2009013808A (es) | Nueva forma cristalina de 3-(difluorometil)-1-metil-n-(3',4',5'-tr ifluoro[1,1'-bifenil]-2-il)-1h-pirazol-4-carboxamida. | |
RS51858B (en) | 4 - [(3-FLUOROPHENOXY) PHENYLMETHYL] PIPERIDINE METANSULPHONATE: ITS USES, PROCESSING METHODS AND PHARMACEUTICAL COMPOSITIONS | |
NO20083583L (no) | Heterosykliske antivirale forbindelser | |
WO2006074270A3 (en) | Synthesis of ccr5 receptor antagonists | |
WO2005123670A3 (en) | Crystalline form of a substituted pyrrolidine compound | |
MX2009006881A (es) | Procesos para la preparacion de antagonistas del receptor ccr-5 utilizando compuestos de 1-ciclopropan-sulfonil-piperidinilo 4-sustituido. | |
MX2009006156A (es) | Proceso para preparar 3,5-di-omicron-acil-2-fluoro-2-c-metil-d-rib ono-gamma-lactona. | |
BR0211140A (pt) | Compostos e composições de indóis de hexaidroazepina (4, 5-g) e indolinas como ligantes de receptores 5-ht | |
AU2712200A (en) | Antidepressant heterocyclic compounds | |
KR20120096086A (ko) | Nk3 수용체 길항제로서 피롤리딘 유도체 |